| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $498K | +191.4% | — |
| R&D Expense | $274K | +12.8% | +8.5% |
| SG&A Expense | $1.5M | +69.0% | +134.6% |
| Operating Income | -$1.3M | -33.8% | -45.1% |
| Net Income | -$1.0M | -33.6% | -15.9% |
| EPS (Basic) | -$0.14 | -27.3% | +77.0% |
| EPS (Diluted) | -$0.14 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $45K | +379.0% | — |
| Current Assets | $13.4M | -7.4% | +93.6% |
| Total Assets | $14.3M | -7.2% | +100.7% |
| Current Liabilities | $452K | -10.6% | +11.6% |
| Total Liabilities | $452K | -10.6% | +11.6% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | — |
| Investing Cash Flow | -$10.4M | — | — |
| Financing Cash Flow | $5.9M | — | — |
| +77.0% |
| $14.1M |
| -6.1% |
| +109.9% |